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Abstract
Background
Physical exercise has been shown to be effective in relation to fatigue, aerobic fitness, and
lower body strength in men with prostate cancer. However, research into the clinically rele-
vant effects of interventions conducted in heterogeneous patient populations and in real-life
clinical practice settings is warranted.
Methods and findings
We conducted a pragmatic, multicentre, parallel randomised controlled trial in 5 Danish uro-
logical departments. Recruitment began in May 2015, the first participant was randomised
in June 2015, and the last participant was included in February 2017. In total, 214 men with
prostate cancer were randomly assigned to either 6 months of free-of-charge football train-
ing twice weekly at a local club (football group [FG]) (n = 109) or usual care (usual care
group [UG]) (n = 105), including brief information on physical activity recommendations at
randomisation. Participants were on average 68.4 (SD 6.2) years old, 157 (73%) were
retired, 87 (41%) were on castration-based treatment, 19 (9%) had received chemotherapy,
and 41 (19%) had skeletal metastases at baseline. In this 1-year follow-up study, we evalu-
ated the effects of community-based football training on the following outcomes: primary
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outcome, quality of life; secondary outcomes: continuation of football after 6 months, hip
and lumbar spine bone mineral density (BMD), mental health score, fat and lean body mass,
and safety outcomes, i.e., fractures, falls, and hospital admissions. Intention to treat (ITT)
and per protocol (PP) analyses were conducted. No statistically significant between-group
difference was observed in change in prostate-cancer-specific quality of life (ITT: 1.9 points
[95% CI −1.9 to 5.8], p = 0.325; PP: 3.6 points [95% CI −0.9 to 8.2], p = 0.119). A statistically
significant between-group difference was observed in change in total hip BMD, in favour of
FG (0.007 g/cm2 [95% CI 0.004 to 0.013], p = 0.037). No differences were observed in
change in lumbar spine BMD or lean body mass. Among patients allocated to football, 59%
chose to continue playing football after the end of the 6-month intervention period. At 1-year
follow-up in the PP population, FG participants had more improvement on the Mental Com-
ponent Summary (2.9 [95% CI 0.0 to 5.7], p = 0.048 points higher) than UG participants, as
well as a greater loss of fat mass (−0.9 kg [95% CI −1.7 to −0.1], p = 0.029). There were no
differences between groups in relation to fractures or falls. Hospital admissions were more
frequent in UG compared to FG (33 versus 20; the odds ratio based on PP analysis was
0.34 for FG compared to UG). There were 3 deaths in FG and 4 in UG. Main limitations of
the study were the physically active control group and assessment of physical activity by
means of self-report.
Conclusions
In this trial, participants allocated to football appeared to have improved hip BMD and fewer
hospital admissions. Men who played football more than once a week for 1 year lost fat
mass and reported improved mental health. Community-based football proved to be accept-
able, even when club membership was not subsidised.
Trial registration
ClinicalTrials.gov NCT02430792.
Author summary
Why was this study done?
• Sports is often referred to as an applicable and useful public health strategy for promot-
ing physical activity in clinical populations, but to our knowledge no randomised con-
trolled trials have examined this possibility in sports clubs.
• Prostate cancer is the most common cancer in men. Men with prostate cancer can suffer
severe morbidity from medical treatments that possibly can be mitigated by exercising
and being physical active.
Community-based football in men with prostate cancer
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What did the researchers do and find?
• We carried out a pragmatic randomised controlled trial involving 214 men with prostate
cancer. Participants were either offered football training in a local club or recommended
to continue their active normal life, and were studied over 1 year.
• We found that more than half of participants allocated to football training continued
with football in the club even when they had to pay their club membership fee
themselves.
• In this setting, men with prostate cancer appeared to have improved hip bone density
and were also admitted to hospital less frequently when allocated to a local football club.
Playing football did not change men’s scores of prostate-cancer-specific quality of life.
The men who played football more than 1 time a week had improved mental health
scores and lost fat mass.
What do these findings mean?
• Clinicians can encourage men with prostate cancer to engage in local sports activities to
mitigate some of the negative effects of medical treatments.
• Sports can be a strategy for some men with prostate cancer in substitution for other
exercise.
• Our findings are limited by the setting the study was implemented in: Denmark is a
country with a highly active population and many local football clubs.
Introduction
The number of men with prostate cancer is increasing; an estimated 5.6 million men are living
with the disease worldwide, and in Europe, prostate cancer is the leading cause of disability
due to cancer [1]. Treatment of the disease, in addition to the disease itself, is a cause of mor-
bidity, including decrease in bone mineral density (BMD), increase in fat mass, and increased
risk of type 2 diabetes mellitus and cardiovascular disease, as well as reduced quality of life [2].
Exercise has been shown to mitigate some of these negative side effects, and physical activity
has been shown to be associated with increased survival [3–5]. In addition, exercise is also sug-
gested to mitigate emotional lability and depression [6]. Exercise, predominately supervised
aerobic and resistance training, has been examined in men with prostate cancer, and 5 trials
have reported outcomes after 1 year of exercising [7–11]. Broadly, the interventions entailed
whole-body resistance training with loads of 6–12 repetition maximum and aerobic exercise at
60%–85% of heart rate maximum; 2 interventions included impact loading. Overall findings
from these trials showed supervised exercise to be safe and efficacious in relation to fatigue,
aerobic fitness, and lower body strength [5,7–11]. However, long-term exercise adherence and
easy accessibility is a concern [12]. It has been proposed that structures in the local community
outside the traditional healthcare system should be used to facilitate the implementation and
upscaling of exercise interventions [13]. Based on this background, we initiated the “FC Pros-
tate” research programme; qualitative findings indicated that participants regarded football as
an opportunity to regain control and acquire a sense of responsibility for their own health
Community-based football in men with prostate cancer
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instead of assuming a passive patient role [14]. Furthermore, our single-centre, phase II trial
showed significant improvement in hip BMD after 32 weeks [15]. To support knowledge on
implementation and generalisability, we subsequently launched FC Prostate Community, a
multicentre, phase III, pragmatic trial that initially allocated participants to 6 months of free-
of-charge football training at a local club and thereafter gave the football participants the
opportunity to continue the intervention by joining the club and paying the membership fee.
The aim was to explore whether patients with prostate cancer accepted exercise in a local
football club under regular conditions (i.e., continued to play football after 6 months including
paying membership fee), and to examine the potential effects of 1 year of community-based
football training in terms of both all randomised participants and just those adhering to the
per protocol (PP) criterion of playing football.
Methods
Study design, participants, and randomisation
The study was a 2-arm, multicentre randomised controlled trial with a 1:1 allocation to either
the football group (FG) or the usual care group (UG). The study was planned with a 6-month
intervention period and a 6-month follow-up period. The FC Prostate Community trial
adheres to the Consolidated Standards of Reporting Trials (CONSORT) guidelines (S1 CON-
SORT checklist). Patients were recruited from 5 Danish urological departments. Detailed
information on the design, randomisation, and participants has been reported [16] (see S1
Trial protocol). In brief, participants were eligible when diagnosed with prostate cancer
regardless of treatment and disease status; only men with osteoporosis (i.e., T-score< 2.5)
were excluded. Randomisation was done with a list of random generated numbers with vary-
ing block sizes (n = 4–8) stratified for centre and treatment (receiving androgen deprivation
therapy [ADT] or not) generated by a statistician not in other ways involved in the trial. The
trial personnel, who randomised participants, were blinded towards the allocation list using a
web-based trial management platform.
Sample size for this trial was based on a detection of a 6-point change in prostate-cancer-
specific quality of life (Pca-QoL) measured with the Functional Assessment of Cancer Ther-
apy–Prostate (FACT-P) questionnaire at 12 weeks. The expected standard deviation was 15
FACT-P points, and a 2-sided significance level of 5% and a power of 80% were chosen. Con-
sequently the trial required a minimum of 100 participants in each arm (for further informa-
tion, see protocol [16]). The trial was conducted in accordance with the Helsinki Declaration
following ethical approval by the local ethics committee (file number H-2-2014-099). All par-
ticipants gave written informed consent before initiating any trial activities. The trial was regis-
tered at ClinicalTrials.gov (NCT02430792), and we have previously reported the outcomes at
12 weeks and 6 months in full compliance with the registration [17].
Intervention
Participants were informed about physical activity guidelines at randomisation. FG partici-
pants were invited to play football for 1 hour twice a week at a local football club. The football
sessions were planned to comprise a 20-minute warm-up based on the FIFA 11+ program
[18], with modified exercises for the upper body, followed by a 20-minute period with drills
and lastly a 20-minute period of match play. After 6 months, participants were invited to con-
tinue the intervention by joining the club on the local club’s terms, e.g., by paying the member-
ship fee. At randomisation, UG participants took part in a 15- to 30-minute telephone session
covering their options for physical activity and free rehabilitation delivered by local municipal-
ities. They did not receive any other offers during the 1-year period [16].
Community-based football in men with prostate cancer
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Outcomes
This 1-year follow-up report presents results on the primary outcome, Pca-QoL, and second-
ary outcomes: continuation of football after 6 months, hip and lumbar spine BMD, mental
health score, fat and lean body mass, and safety outcomes, i.e., fractures, falls, and hospital
admissions. Changes in hip and spine BMD and in lean and fat body mass were assessed with
dual-energy X-ray absorptiometry (DXA). DXA assessors were blinded to participants’ group
allocation. Patient-reported outcomes were Pca-QoL, measured with the FACT-P question-
naire [19]; mental health, assessed by the Mental Component Summary of Short Form-12
together with the individual outcomes of the vitality, social function, role-emotional, and men-
tal health scales [20]; and physical activity, measured with the short International Physical
Activity Questionnaire (IPAQ) [21]. Safety outcomes were numbers of fractures and falls
requiring medical assessment and hospital admissions. Safety outcomes were assessed through
self-report from participants and review of central medical records (from all Danish hospitals).
The patient-reported outcomes were obtained using a web-based data capture system.
We also report the number of FG participants who continued playing football after the
6-month intervention, defined as attending more than 5 training sessions, as well as the num-
ber who attended 50% or more of the training sessions during the 1-year period.
Outcomes were assessed at 12 weeks, 6 months, and 1 year. The 12-week and 6-month out-
come results have been reported elsewhere [17].
Data analysis
We report 2 types of analysis, one on the intention to treat (ITT) population, i.e., all partici-
pants randomised at baseline, and the other on the PP population, i.e., including only those
FG participants who adhered to the a priori PP attendance rate of a minimum of 50% of train-
ing sessions [16]. The ITT population was analysed using the same statistical strategy described
in our protocol for the 12-week and 6-month data [17]. The analyses on the PP population
were performed with the use of principles proposed by Herna´n and colleagues [22,23]. We
adjusted these analyses for prognostic risk factors known at baseline. We used the prognostic
risk factors to adjust for the confounding that cannot be stratified for and that may arise when
only a subgroup of participants (PP population) is analysed.
For ITT analyses of continuous outcomes, we compared change scores between allocation
groups using analysis of covariance, where we included the allocation group and adjusted for age
and the stratification factor ADT. Between-group differences are presented as marginal mean
differences between allocation groups with 95% confidence intervals and p-values. For binary
outcomes, we used the chi-squared test to compare differences in proportions. PP analyses on
continuous outcomes included allocation group and adjusted for the following baseline values in
the model: age, smoking, alcohol consumption, employment, education, marital status, disease
stage, tumour grade (Gleason score), prostate cancer treatment, and co-morbidities. For binary
outcomes, we used logistic regression models to allow for adjustment of the same variables list as
in the analyses of continuous outcomes. All figures show results from reported models. For all
models, we checked the distribution of continuous variables for normality, and residuals were
scrutinised to validate models. No imputation of missing data was performed as we had low attri-
tion and most missing data were related to death or progression of disease, which were equally
distributed between groups. All analyses were done with STATA 15 version 1.
Results
From June 2015 to February 2017, 214 men were randomised to either FG (n = 109) or UG
(n = 105). Retention, similar in the 2 arms of the study, was 95% at the end of the 6-month
Community-based football in men with prostate cancer
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002936 October 1, 2019 5 / 15
intervention period and 92% at 1 year for patient-reported outcomes (n = 197) and 87% at 1
year for DXA outcomes (n = 187) (Fig 1). Sixty-four FG participants (59%) chose to continue
playing football after completion of the 6-month intervention, 78% of whom (n = 50) attended
�50% of the training sessions during the 1-year period. No significant differences existed
between FG and UG at baseline (Table 1). Comparing FG participants who attended�50% of
the training sessions to the ones who attended <50% showed no differences in the outcome
variables at baseline, but the groups differed with regard to marital status and number of co-
Fig 1. CONSORT 2010 flow diagram.
https://doi.org/10.1371/journal.pmed.1002936.g001
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Table 1. Baseline characteristics of patients according to allocation group.
Usual care group
(n = 105)
Football group Total (n = 214)
Allocated to football group
(n = 109)
Played football
(n = 50)
Age (years) 69.0 (6.2) 67.8 (6.2) 67.5 (5.9) 68.4 (6.2)
Employment status
Paid work 26 (25%) 26 (24%) 11 (22%) 52 (24%)
Unemployed 0 (0%) 2 (2%) 1 (2%) 2 (1%)
Sick leave 2 (2%) 1 (1%) 0 (0%) 3 (1%)
Retired 77 (73%) 80 (73%) 38 (76%) 157 (73%)
Education
No completed education 5 (5%) 7 (6%) 2 (4%) 12 (6%)
Primary education (9th/10th grade) 5 (5%) 4 (4%) 2 (4%) 9 (4%)
Vocational education 28 (27%) 33 (30%) 13 (26%) 61 (29%)
Secondary education (12th grade) 15 (14%) 10 (9%) 6 (12%) 25 (12%)
Completed college or higher 52 (50%) 55 (50%) 27 (54%) 107 (50%)
Marital status
Married or living with partner 93 (89%) 92 (84%) 48 (96%) 185 (86%)
Other (single, divorced, or widowed) 12 (11%) 17 (16%) 2 (4%) 29 (14%)
Smoking
Yes 11 (10%) 17 (16%) 5 (10%) 28 (13%)
No, stopped 51 (49%) 49 (45%) 24 (48%) 100 (47%)
No, never 43 (41%) 43 (39%) 21 (42%) 86 (40%)
Alcohol consumption (units of alcohol per week) 8.5 (7.0) 9.1 (7.2) 8.8 (8.0) 8.8 (7.1)
Disease stage
Localised, prostatectomised 15 (14%) 16 (15%) 9 (18%) 31 (14%)
Localised, not prostatectomised 28 (27%) 27 (25%) 14 (28%) 55 (26%)
Locally advanced 42 (40%) 39 (36%) 17 (34%) 81 (38%)
Metastatic 19 (18%) 26 (24%) 10 (20%) 45 (21%)
Unknown 1 (1%) 1 (1%) 0 (0%) 2 (1%)
ISUP Gleason grading
Group 1 (Gleason score 2–6) 13 (12%) 15 (14%) 8 (16%) 28 (13%)
Group 2 (Gleason score 3 + 4) 36 (34%) 29 (27%) 17 (34%) 65 (30%)
Group 3 (Gleason score 4 + 3) 13 (12%) 18 (17%) 6 (12%) 31 (14%)
Group 4 (Gleason score 8) 13 (12%) 18 (17%) 9 (18%) 31 (14%)
Group 5 (Gleason score 9–10) 24 (23%) 28 (26%) 10 (20%) 52 (24%)
Unknown 6 (6%) 1 (1%) 0 (0%) 7 (3%)
Number of men with bone metastasis 19 (18%) 22 (20%) 7 (14%) 41 (19%)
Current treatment at baseline
No treatment (watchful waiting, active surveillance, or previous
prostatectomy or radiation)
42 (40%) 46 (42%) 24 (48%) 88 (41%)
Anti-androgen monotherapy 21 (20%) 15 (14%) 7 (14%) 36 (17%)
Castration (surgical or pharmacological) 41 (39%) 46 (42%) 19 (38%) 87 (41%)
Unknown 1 (1%) 2 (2%) 0 (0%) 3 (1%)
Previous treatment at baseline
Prostatectomy 39 (37%) 27 (25%) 14 (28%) 66 (31%)
Radiation 29 (28%) 37 (34%) 16 (32%) 66 (31%)
ADT and radiation with curative intent 16 (15%) 21 (19%) 9 (18%) 37 (17%)
Chemotherapy (docetaxel) 10 (10%) 9 (8%) 4 (8%) 19 (9%)
No prior or current treatment 24 (22%) 21 (20%) 13 (26%) 45 (21%)
(Continued)
Community-based football in men with prostate cancer
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002936 October 1, 2019 7 / 15
morbidities (S1 Table). During the conduct of the trial, 616 football sessions were held across
sites. On average, sessions took 58.8 (58.4–59.3) minutes, with 20.4 (20.0–20.8) minutes spent
on warm-up, 16.1 (15.5–16.6) minutes on drills, and 22.3 (21.8–22.9) minutes on match play.
DXA outcomes
A statistically significant between-group difference in favour of FG was observed in change in
total hip BMD in the ITT population (0.007 g/cm2 [95% CI 0.004 to 0.013], p = 0.037) and the
PP population (0.007 g/cm2 [95% CI 0.000 to 0.015], p = 0.046) (Tables 2 and 3). Change in
Table 1. (Continued)
Usual care group
(n = 105)
Football group Total (n = 214)
Allocated to football group
(n = 109)
Played football
(n = 50)
Number of co-morbidities
0 36 (34%) 28 (26%) 11 (22%) 64 (30%)
1 41 (39%) 38 (35%) 24 (48%) 79 (37%)
2 16 (15%) 30 (28%) 13 (26%) 46 (22%)
3 or more 12 (11%) 13 (12%) 2 (4%) 25 (12%)
Baseline values on outcomes
Prostate-cancer-specific quality of life (FACT-P, points) 124.6 (16.6) 123.7 (17.3) 124.8 (16.9) 124.1 (16.9)
Mental Component Summary (Short Form-12, points) 52.9 (7.8) 52.8 (6.6) 52.8 (6.2) 52.9 (7.2)
Lean body mass (kg) 57.5 (7.1) 56.6 (6.3) 56.6 (5.5) 57.0 (6.7)
Fat mass (kg) 28.3 (8.9) 27.5 (8.0) 26.8 (8.3) 27.9 (8.4)
Total hip BMD (g/cm2) 1.025 (0.138) 1.015 (0.132) 1.005 (0.132) 1.020 (0.134)
Lumbar BMD (g/cm2) 1.189 (0.223) 1.188 (0.226) 1.177 (0.216) 1.188 (0.224)
Weekly self-reported physical activity (median MET)a 4,098
(2,394–7,732)
3,649
(1,824–6,693)
4,686
(2,631–6,786)
4,046
(2,010–6,845)
Data are mean (standard deviation), n (%), or median (interquartile range).
a102 patients in the football group and 96 patients in the usual care group.
ADT, androgen deprivation therapy; BMD, bone mineral density; FACT-P, Functional Assessment of Cancer Therapy–Prostate; ISUP, International Society of
Urological Pathology; MET, metabolic equivalent of task.
https://doi.org/10.1371/journal.pmed.1002936.t001
Table 2. Outcomes at 1 year based on intention to treat population.
Outcome Usual care group Football group Effectiveness analysis:
Difference between groups
adjusted for ADT, age, and
baseline score
n Mean (95% CI) N Mean (95% CI) Mean (95% CI) p-Value
Change in lean body mass (kg) 90 −0.1 (−0.4 to 0.3) 97 −0.3 (−0.6 to 0.0) −0.2 (−0.7 to 0.2) 0.339
Change in fat mass (kg) 90 0.3 (−0.2 to 0.8) 97 −0.3 (−0.8 to 0.2) −0.6 (−1.3 to 0.1) 0.108
Change in total hip bone mineral density (g/cm2) 90 0.001 (−0.003 to 0.006) 97 0.008 (0.003 to 0.012) 0.007 (0.004 to 0.013) 0.037
Change in lumbar spine L1–L4 bone mineral density (g/cm2) 89 0.009 (−0.000 to 0.018) 96 0.017 (0.008 to 0.027) 0.008 (−0.005 to 0.022) 0.215
Change in prostate-cancer-specific quality of life (FACT-P total score,
higher is better)
97 −4.2 (−6.9 to −1.4) 100 −2.2 (−4.9 to 0.5) 1.9 (−1.9 to 5.8) 0.325
Change in mental health scale (SF-12, higher is better) 97 −2.1 (−3.8 to −0.4) 100 0.2 (−1.4 to 1.9) 2.3 (−0.1 to 4.7) 0.055
Change in Mental Component Summary (SF-12, higher is better) 97 −1.9 (−3.5 to −0.4) 100 0.2 (−1.3 to 1.8) 2.2 (−0.0 to 4.4) 0.054
FACT-P, Functional Assessment of Cancer Therapy–Prostate; SF-12, Short Form-12.
https://doi.org/10.1371/journal.pmed.1002936.t002
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spine BMD did not show any statistical difference between groups in the ITT population
(0.008 g/cm2 [95% CI −0.005 to 0.022], p = 0.215) or the PP population (0.003 g/cm2 [95% CI
−0.012 to 0.019], p = 0.673). No between-group differences were observed in change in lean
body mass in either the ITT population (−0.2 kg [95% CI −0.7 to 0.2], p = 0.339) or the PP pop-
ulation (0.2 kg [95% CI −0.3 to 0.7], p = 0.506). The between-group difference in change in fat
mass was −0.6 kg (95% CI −1.3 to 0.1, p = 0.108) in the ITT analysis and −0.9 kg (95% CI −1.7
to −0.1, p = 0.029) in the PP analysis, i.e., FG participants lost more fat mass than UG partici-
pants after 1 year (Fig 2).
Table 3. Outcomes at 1 year based on per protocol population.
Outcome Usual care group Played football Efficacy analysis: Difference
between groups adjusted for
risk variables�
n Mean (95% CI) n Mean (95% CI) Mean (95% CI) p-Value
Change in lean body mass (kg) 90 −0.2 (−0.5 to 0.2) 48 0.0 (−0.4 to 0.4) 0.2 (−0.3 to 0.7) 0.506
Change in fat mass (kg) 90 0.3 (−0.2 to 0.8) 50 −0.6 (−1.3 to 0.0) −0.9 (−1.7 to −0.1) 0.029
Change in total hip bone mineral density (g/cm2) 90 0.001 (−0.003 to 0.005) 50 0.008 (0.003 to 0.014) 0.007 (0.000 to 0.015) 0.046
Change in lumbar spine L1–L4 bone mineral density (g/cm2) 89 0.012 (0.002 to 0.021) 48 0.015 (0.003 to 0.027) 0.003 (−0.012 to 0.019) 0.673
Change in prostate-cancer-specific quality of life (FACT-P total score,
higher is better)
97 −5.0 (−7.6 to −2.3) 50 −1.3 (−5.0 to 2.3) 3.6 (−0.9 to 8.2) 0.119
Change in mental health scale (SF-12, higher is better) 97 −1.8 (−3.6 to −0.1) 49 1.7 (−0.7 to 4.1) 3.5 (0.6 to 6.5) 0.020
Change in Mental Component Summary (SF-12, higher is better) 97 −1.8 (−3.5 to −0.2) 49 1.0 (−1.2 to 3.3) 2.9 (0.0 to 5.7) 0.048
�Risk variables used to adjust for confounding when analysing efficacy: baseline value, age, smoking, alcohol consumption, employment status, education, marital status,
disease stage, Gleason score, treatment, and co-morbidities.
FACT-P, Functional Assessment of Cancer Therapy–Prostate; SF-12, Short Form-12.
https://doi.org/10.1371/journal.pmed.1002936.t003
Fig 2. Fat mass changes for per protocol football participants compared to usual care participants.
https://doi.org/10.1371/journal.pmed.1002936.g002
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Patient-reported outcomes
For the both the ITT and PP population, Pca-QoL showed no statistical significant difference
between groups (change in ITT population: 1.9 points [95% CI −1.9 to 5.8], p = 0.325; change
in PP population: 3.6 points [95% CI −0.9 to 8.2], p = 0.119). In the ITT population, changes in
mental health—both the Mental Component Summary score and the specific mental health
scale score—were non-statistically higher in FG than UG (summary: 2.2 points [95% CI −0.0
to 4.4], p = 0.054; subscale: 2.3 points [95% CI −0.1 to 4.7], p = 0.055).
In the PP population, reported mental health was significantly more improved in FG than
UG over 1 year, both on the Mental Component Summary and the specific mental health scale
(summary: 2.9 points [95% CI 0.0 to 5.7], p = 0.048; subscale: 3.5 points [95% CI 0.6 to 6.5],
p = 0.020). Subdomains for patient-reported outcomes are reported in S2 Table (ITT analysis)
and S3 Table (PP analysis).
Safety, physical activity, and health-specific outcomes
For the ITT population, the overall number of falls was 13 in FG and 10 in UG, with 1 partici-
pant in each group reporting 2 falls (p = 0.699). Two fractures were reported in each group.
The corresponding odds ratio for sustaining a fracture when playing football at least 1 time a
week (PP analysis) was 2.58 (p = 0.398) for FG compared to UG.
We found no significant differences between groups with respect to self-reported physical
activity behaviour; both groups reported higher metabolic equivalent of task (MET) values at 1
year than at baseline, with a median increase of 387 (IQR 3,539) for FG and 589 (IQR 5,899)
for UG.
The number of hospital admissions was significantly different between groups in the ITT
population, with 20 in FG and 33 in UG (p = 0.016). The corresponding odds ratio for the risk
of having a hospital admission when playing football at least 1 time a week (PP analysis) was
0.34 (p = 0.042) for FG compared to UG (Tables 4 and 5).
Discussion
In this 1-year follow-up study on the effects of community-based football training, more than
half of the participants initially randomised to playing football opted to continue playing foot-
ball at their own expense after completion of the 6-month intervention period. Participants
allocated to FG did not report the same decline in quality of life apparent in UG, and their
Table 4. Safety outcomes based on ITT population.
Safety outcome Usual care group (n = 105) Football group (n = 109) p-Value
Falls
1 8 11
2 1 1
Total 10 13 0.699
Fractures 2 2 0.966
Hospital admissions
1 12 17
2 9 0
3 1 1
Total 33 20 0.016
ITT, intention to treat.
https://doi.org/10.1371/journal.pmed.1002936.t004
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mental health improved. Being in FG improved total hip BMD, and playing football regularly
was associated with a 0.9-kg decrease in fat mass. There was no difference between the groups
in regard to falls and fractures; a lower number of all-cause hospital admissions was observed
in FG, when analysing both the ITT population and the PP population.
The findings of this 1-year follow-up are in most outcomes consistent with the short-term
report on the time points 3 and 6 months [17]. However, differences are seen in hip BMD,
Mental Component Summary, and hospital admissions, as well as in fat mass changes in PP
analyses. The small improvement seen in hip BMD at 1 year, but not at earlier time points, is
consistent with the finding in our first smaller explanatory phase II trial, where hip BMD
improvements also first were seen at that trial’s 32-week time point [15]. As the process of
bone remodelling is slow, it is recognised in radiologist guidelines that BMD changes at the
earliest should be evaluated after 6 months when looking at high potent interventions [24].
Moreover, the guidelines regard exercise and other lifestyle interventions as having a low-to-
moderate potent effect, thus requiring even longer follow-up times [24]. In addition, the fact
that the change is found only in hip BMD and not spine is consistent with the biomechanical
loading pattern of football [25]. Previously, at 6 months, statistically significant differences
between groups were observed in the Mental Component Summary both based on ITT and
PP analyses [17]. In this 1-year report, it is only in the PP analysis that this effect is seen. A pos-
sible explanation for this difference is that 41% of participants randomised to FG did not con-
tinue with the football intervention, but were still included in the ITT analyses. In support of
this explanation, it should be noted that the magnitude of the difference in the Mental Compo-
nent Summary (i.e., 2.9 points) reported in this follow-up in the PP analysis is similar to that at
the 6-month time point (ITT, 2.7 points; PP, 2.5 points). The number of hospital admissions
was not statistically significantly different between groups after 6 months, as FG had 11 and
UG had 22 (p = 0.12) [17]. We believe that the reason why this outcome reached significance
after 12 months has to do with the accumulation of the number of hospital admissions from 6
to 12 months, which increased statistical power. Lastly, we observed a statistically significant
between-group difference in fat mass change in the PP analysis after 1 year but not after 6
months. This may also be explained by an accumulated effect over time in the men actively
engaging in the intervention (for more than 6 months), whereas the men in the control group
and the men in FG who did not adhere to football longer term (>6 months) did not lose fat.
To our knowledge, football training is the first type of exercise intervention in men with
prostate cancer to show improvement in hip BMD. Our small-scale, single-centre randomised
controlled trial, conducted in 2012–2013, previously showed improved hip strength in men
Table 5. Safety outcomes based on PP population.
Safety outcome Usual care group (n = 105) Played football (n = 50) Odds ratio, p-Value
Falls
1 8 7
2 1 0 1.36, p = 0.602
Fractures 2 2 2.58, p = 0.398
Hospital admissions
1 12 6
2 9 0
3 1 0
Total 33 6 0.34, p = 0.042
PP, per protocol.
https://doi.org/10.1371/journal.pmed.1002936.t005
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with prostate cancer on ADT at 32 weeks [15], and this confirmatory multicentre study cor-
roborates this finding in a larger and more heterogenic population and a more real-world set-
ting. Winters-Stone et al. examined resistance and impact loading and found no skeletal
improvement in hip BMD [9]. One possible explanation for the discrepancy between the find-
ings of that study and ours is that impact loading from football varies constantly, and partici-
pants have the ability to adjust naturally in response to the intensity of accelerations and
decelerations [26]. One of the possible consequences or trade-offs of higher intensity is a
greater risk of bone fractures. Although not significant, FG participants had a higher odds
ratio for sustaining fractures; however, overall fractures were equally distributed among the
allocation groups. The men attending�50% of sessions over 1 year decreased their fat mass by
0.9 kg regardless of treatment (ADT or non-ADT). In this regard it is worth noting that, while
exercise is already accepted as a strategy to mitigate treatment-induced increases in fat mass in
men undergoing ADT [2], reducing fat mass in men with low-risk prostate cancer may also
prove beneficial, as obesity has been associated with progression in patients on active surveil-
lance [27].
Men with prostate cancer are at risk of experiencing psychological distress during the
course of their disease [6,28]. In a previous study we found that men experienced football as an
opportunity to regain control [14], which is why the improved mental health finding, also con-
firmed by the 6-month report [17], was anticipated. Furthermore, this finding is in line with
the results from a recently published trial by Taaffe et al., who found that supervised group-
based exercise positively affected vitality and fatigue [10]. In another exercise trial, however,
Galvão et al. did not find any changes in mental health, despite positive effects on cardiorespi-
ratory fitness and physical functioning [8]. The complexity of exercise as a behavioural inter-
vention is one possible explanation for these conflicting findings. Exercise can be performed in
many different settings, and it can be individually tailored, to maximise the physiological
effect, and/or group-based, to enable peer-to-peer relationships. Individually tailored exercise
gives the possibility of specific prescription of exercise modes, volume, and intensity; this,
however, is not possible with football as the volume and intensity is auto-regulated by partici-
pants. The fact that FG participants had fewer hospital admissions was surprising, We are
unable to offer a comprehensive explanation for this finding but propose that the greater level
of control and insight the men experienced regarding their own health, combined with the
support of their peers, may possibly have been a contributing factor [14]. This finding can be a
possible avenue of continued exploration in the next generation of exercise trials in men with
prostate cancer focusing on exercise as a primary therapy option [11,29].
Our study has various methodological limitations. The analysis of physical activity behav-
iour was hampered due to large variation in the sample, which is a known methodological
issue concerning the responsiveness of IPAQ when used in clinical trials [30]. If the respon-
siveness of IPAQ is inaccurate, it reduces the reliability of the physical activity change data. If
we look beyond the mentioned validity issue related to physical activity change, another possi-
ble limitation is that the sampled participants reported being highly physically active (i.e.,
above recommendations) already at baseline and adhered to this level throughout the trial.
This has most likely resulted in an underestimation of the effect of the intervention as we com-
pared a group (i.e., FG) that most likely substituted their normal exercise with football with a
control group that appeared to have continued their normal (high) activity level. However, this
being a pragmatic trial, we wanted to include a sample that would engage in the intervention
in real life. In this perspective, our results are probably a fair reflection of what can be expected
under natural circumstances, and may as such be interpreted as successful. Due to the prag-
matic design of the trial, the various features of the heterogenic population (i.e., varied disease
and co-morbidity status, as seen in Table 1) need to be scrutinised; the study design optimises
Community-based football in men with prostate cancer
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002936 October 1, 2019 12 / 15
generalisability, but effect modification between subgroups can reduce the ability to infer from
analyses. As a result, we stratified randomisation on the ADT population and checked if differ-
ential effects were present in subgroups, but this was not the case. Furthermore, we adjusted
PP analyses for the prognostic risk variables at baseline that would confound these analyses.
Another issue related to generalisability is that the intervention was implemented in Denmark,
a high-income country with many local amateur sports clubs, enabling a reciprocal partner-
ship between hospitals and the local community, which may not be a viable strategy if this
infrastructure is not available.
Conclusions
The current trial is, to our knowledge, the first pragmatic randomised controlled trial to exam-
ine the effects of sports participation in a clinical population. Community-based football
proved to be an acceptable intervention, even when participants had to pay the membership
fee themselves. In this trial, participants allocated to football appeared to have improved hip
BMD and fewer hospital admissions. Furthermore, the men who played more than once a
week for 1 year improved their mental health and lost fat mass. Future studies should focus on
examining the clinically relevant effects of exercise, while implementation studies should
explore the accessibility of exercise tailored to local infrastructures.
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